![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Multicenter Experience using Sofosbuvir and Simeprevir with/without Ribavirin to Treat HCV Genotype 1 after Liver Transplantation
|
|
|
Reported by Jules Levin
AASLD Nov 9 2014
Surakit Pungpapong, K. Tuesday Werner, Bashar Aqel,
Michael Leise, Jennifer L. Murphy, Tanisha M. Henry, Kristen Ryland, Amy E. Chervenak, Kymberly D. Watt, Hugo E. Vargas, Andrew Keaveny
Department of Transplant, Mayo Clinic Jacksonville, FL
Division of Hepatology, Mayo Clinic Scottsdale, AZ
Division of Gastroenterology & Hepatology, Mayo Clinic Rochester, MN
![AASLD1.gif](../images/111014/111014-2/AASLD1.gif)
![AASLD2.gif](../images/111014/111014-2/AASLD2.gif)
![AASLD3.gif](../images/111014/111014-2/AASLD3.gif)
![AASLD4.gif](../images/111014/111014-2/AASLD4.gif)
![AASLD5.gif](../images/111014/111014-2/AASLD5.gif)
![AASLD6.gif](../images/111014/111014-2/AASLD6.gif)
![AASLD7.gif](../images/111014/111014-2/AASLD7.gif)
![AASLD8.gif](../images/111014/111014-2/AASLD8.gif)
![AASLD9.gif](../images/111014/111014-2/AASLD9.gif)
![AASLD10.gif](../images/111014/111014-2/AASLD10.gif)
![AASLD11.gif](../images/111014/111014-2/AASLD11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|